Health Analysis: Chinese pharma giant facing US ban may redirect investment to Ireland Companies part of the WuXi group that face restrictions by US lawmakers have invested more than €500 million into Ireland in the past five years
Companies Chinese pharma giant pumps $350m into dormant Irish entityWuxi AppTec was recently named as a ‘company of concern’ by US lawmakers over alleged links to the Chinese military
WuXi Biologics Ireland doubles turnover to €16.1 million in 2022Company also trimmed its expenses during the year to €16.7 million, leaving it with a pre-tax loss of €6.9 million, down from €12.2 million the year before
Inside story: How Chinese biopharma firm WuXi will target European market from its €1 billion Dundalk campusIn what marks a first major foreign direct investment by a Chinese multinational in this country, WuXi has built one of the largest biopharma campuses in the world where it plans to produce 50 million vaccine doses a year – the Business Post